Crescent Sterling, Ltd.’s Johnson & Johnson Position
Does Crescent Sterling, Ltd. own Johnson & Johnson (JNJ)? Yes — 22.1K shares worth $6M (+5.01% of its 13F portfolio) as of Q2 2026, up from 21.9K shares the prior filed quarter.
Position Value
$6M
Q2 2026
Shares
22.1K
% of Portfolio
+5.01%
Quarters Held
15
currently held
Position History JNJ
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2026 | 22.1K | $6M | +5.01% |
| Q1 2026 | 21.9K | $5M | +5.18% |
| Q4 2025 | 21.9K | $5M | +4.65% |
| Q3 2025 | 22.0K | $4M | +4.29% |
| Q2 2025 | 22.2K | $3M | +3.80% |
| Q1 2025 | 23.6K | $4M | +4.02% |
| Q4 2024 | 23.2K | $3M | +3.45% |
| Q3 2024 | 23.2K | $4M | +3.58% |
| Q2 2024 | 23.1K | $3M | +3.24% |
| Q1 2024 | 23.3K | $4M | +3.36% |
| Q4 2023 | 23.8K | $4M | +3.72% |
| Q3 2023 | 24.6K | $4M | +4.05% |
| Q2 2023 | 30.6K | $5M | +4.80% |
| Q1 2023 | 29.9K | $5M | +4.50% |
| Q4 2022 | 26.9K | $5M | +5.11% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Crescent Sterling, Ltd.’s full portfolio or all institutional holders of JNJ.